PHARMACOECONOMIC ANALYSIS OF CHICKENPOX IMMUNE PREVENTION EFFECTIVENESS IN THE INFANT ORPHANAGE INMATES
https://doi.org/10.15690/pf.v11i6.1212
Abstract
Background. Chickenpox is the second most common cause of pediatric infectious pathologies. Specific chickenpox immune prevention has been in use around the world for more than 20 years. The main reasons why chickenpox vaccine has not been included into the national immunization schedule in the territory of the Russian Federation is high price of imported vaccines and the lack of effective and inexpensive Russian counterparts, which is why economic feasibility of expenses on immune prevention against this disease is doubtful. The study was aimed at assessing pharmacoeconomic effectiveness and safety of chickenpox immunization of the infant orphanage inmates on the basis of the retrospective analysis of chickenpox incidence. Methods. Statistical data of the specialized infant orphanage (overall hospital admission rate and chickenpox incidence) for 10 years (2004–2013) have been compared with one-year chickenpox incidence among the children immunized with hypodermic freeze-dried vaccines based on the attenuated Varicella zoster virus (OKA strain) reproduced in the culture of diploid MRC-5 cells. Results. Significance of chickenpox in the morbidity structure of the infant orphanage inmates aged 0-4 years has been demonstrated. Conclusions. Retrospective pharmacoeconomic analysis helped to confirm effectiveness and financial viability of immunizing infant orphanage inmates against chickenpox.
About the Authors
D. V. Raiskii
Astrakhan State Medical University, Russian Federation
Russian Federation
Russian Federation
A. A. Dzhumagaziev
Astrakhan State Medical University, Russian Federation
Russian Federation
Russian Federation
E. I. Dzhal'mukhamedova
Specialized Infant Hospital No. 1 “Zvezdochka”, Astrakhan, Russian Federation
Russian Federation
Russian Federation
I. E. Kvyatkovskii
Ministry of Health of the Astrakhan Region, Russian Federation
Russian Federation
Russian Federation
References
1. Baranov A.A., Namazova-Baranova L.S., Tatochenko V.K. Scientific substantiation of vaccination of children with disabilities in the state of health. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2010; 7 (2): 6─23.
2. Lagir G.M., Mankevich R.N., Miklashevskaya V.N. Vetryanaya ospa u rebenka pervogo mesyatsa zhizni (Chickenpox in children of the first month of life). Available at: http://webcache.googleusercontent.com/search?q=cache:http://www.bsmu.by/files/504ebca35692549b1ff05aaa809fd927/ (accessed 07.01.2014).
3. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2013 godu: Gosudarstvennyi doklad (On the state sanitary and epidemiological welfare of the population in the Russian Federation in 2013: State report). Moscow, Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka, 2014. 191 p. Available at: www.rospotrebnadzor.ru/docs/doclad (accessed 07.01.2014)
4. Yakubenko A.L., Glushchenko A.A. Vetryanaya ospa u vzroslykh. Zdorov'e — osnova chelovecheskogo potentsiala: problemy i puti ikh resheniya: Trudy 8-i Vseros. nauch.-prakt. konf. s mezhdunar. uchastiem (Chickenpox in Adults. Health - the Basis of Human Development: Problems and Ways to Solve them. Proceedings of the 8th Russian National Scientific and Practical Conf. with Int. Participation). 2013; 8 (2): 621─623.
5. Ivanova G.P., Skripchenko E.Yu., Komantsev V.N., Ivanova M.V., Murina E.A. Prichiny tyazhesti techeniya vetryanochnykh entsefalitov u detei. Zdorov'e — osnova chelovecheskogo potentsiala: problemy i puti ikh resheniya: Trudy 8-i Vseros. nauch.-prakt. konf. s mezhdunar. uchastiem (The Reasons for the Severity of Varicella Encephalitis in Children. Health - the Basis of Human Development: Problems and Ways to Solve them. Proceedings of the 8th Russian National Scientific and Practical Conf. with Int. Participation). 2013; 8 (2): 559─561.
6. Skripchenko E.Yu. Nevrologicheskie oslozhneniya i prognoz ikh razvitiya pri vetryanoi ospe u detei. Avtoref. dis. …kand. med. nauk [Neurological complications and prognosis of their development varicella in children. Author’s abstract]. St. Petersburg, 2013. 24 p.
7. Rumyantsev A.G. The efficacy and safety of vaccination against varicella in children. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2007; 4 (5): 11─17.
8. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2012 godu: Gosudarstvennyi doklad (On the state sanitary and epidemiological welfare of the population in the Russian Federation in 2012: State report). Moscow, Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka, 2013. 176 p. Available at: www.rospotrebnadzor.ru/docs/doclad (accessed 07.01.2014).
9. Zueva L.P., Yafaev R.Kh. Infektsiya, vyzyvaemaya virusom varitsella zoster: vetryanaya ospa i opoyasyvayushchii lishai. Epidemiologiya [Infection caused by varicella zoster virus: chicken pox and shingles. Epidemiology]. St. Petersburg, Foliant, 2005. P. 358–365.
10. Panasyuk Yu.V., Romanova O.N., Guzovskaya T.S. Zabolevanie vetryanoi ospoi u rebenka v vozraste 4 mesyatsev (Varicella disease in a child under the age of 4 months). Available at: www.bsmu.by/medicaljournal/268d436bdb7a0bbb3afaf4fe49187188/ (accessed 07.01.2014).
11. Krasnova E.I., Gaints O.V., Gavrilova N.I., Kuimova I.V., Vasyunin A.V. Hemorrhagic form of chickenpox in children and its outcomes based on my own observations: opportunities for prevention. Lechashchii vrach = The attending physician. 2012; 3: 65─68.
12. Lobzin Yu.V., Skripchenko E.Yu., Karev V.E., Pal'chik A.B. Congenital varicella: urgency of the problem and a clinical case. Rossiiskii vestnik perinatologii i pediatrii = Russian bulletin of perinatology and pediatrics. 2012; 57 (2): 64─70.
13. Timchenko V.N. Vozdushno-kapel'nye infektsii v praktike pediatra i semeinogo vracha: rukovodstvo dlya vrachei vsekh spetsial'nostei [Airborne infection in pediatric practice and family physicians: a guide for health care professionals]. St. Petersburg, ELBI-SPb, 2007. P. 208–217.
14. Matveev V.A., Shevtsova V.V. Infektsiya, vyzyvaemaya Varicella-Zoster virusom: ucheb.-metod. posobie [Infection caused by Varicella-Zoster virus: Tutorial]. Minsk, 2009. 32 p.
15. Nathwani D., Maclean A., Conway S. et al. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998; 36 (1): 59─71.
16. Georgala S. Vetryanaya ospa. Evropeiskoe rukovodstvo po lecheniyu dermatologicheskikh boleznei. Pod red. A.D. Katsambasa, T.M. Lotti. Per. s angl. [Varicella. European guidelines for the treatment of dermatological diseases. Ed. by A.D. Katsambasa, T.M. Lottie. Trans. from English]. Moscow, MEDpress-inform, 2008. 736 p.
17. NACI. National Advisory Committee on Immunization (NACI) update on varicella. Can Commun Dis Rep. 2004; 30: 1─26.
18. Enders G., Miller E., Cradock-Watson J., Bolley I., Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994 Jun 18; 343 (8912): 1548─1551.
19. Strachunskii L.N., Kandalov M.M. Principles of drug trials in children. Detskii doctor = Pediatrician. 1999; 3: 6─9.
20. ACIP. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999 May 28; 48 (6): 1–5.
21. Dzhumagaziev A.A., Raiskii D.V., Dzhal'mukhamedova E.I., Khalturina I.L., Chilikova E.V. S. pneumonia immunization reduces the incidence of acute otitis media in children's home pupils (preliminary results). Zhurnal infektologii = Journal of infectology. 2012; 4 (3): 76─79.
22. Immunoprofilaktika infektsionnykh boleznei. Ekonomicheskaya effektivnost' immunoprofilaktiki. Metodika. MU 3.3.1878-04. (utv. Glavnym gosudarstvennym sanitarnym vrachom RF 4.03.2004 g.) [Immunization of Infectious Diseases. Cost-effectiveness of immunization. Methods. MU 3.3.1878-04. (App. Chief Medical Officer of the Russian Federation dated 03.04.2004)]. Moscow, 2004. 14 p.
23. Kulikov A.Yu., Akimova Yu.I. The methodology of pharmacoeconomic analysis of vaccinal. Sovremennaya farmakoekonomika i farmakoepidemiologiya = Modern pharmacoeconomics and pharmacoepidemiology. 2013; 6 (1): 4─10.
24. Deineko O.Ya., Avdeeva T.G., Sulimova N.V., Trashchenkova D.N. The incidence of chickenpox children from high-risk groups: epidemiological and clinical features of the disease and the cost of a possible cost-effectiveness of vaccination. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2011; 6 (8): 12─16.
25. Kramar' L.V., Arova A.A., Seikina E.A., Alyushin A.M. Rationale and experience in the use of the vaccine for the prevention of varicella in Volgograd. Voprosy sovremennoi pediatrii = Current Pediatrics. 2012; 3 (11): 79─82.
26. Briko N.I. Evaluation of the quality and effectiveness of the immunization. Lechashchii vrach = The attending physician. 2012; 10: 57─63.
27. Michalik D.E., Steinberg S.P., Larussa P.S. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008; 197: 944─949.
28. Vishneva E.A., Namazova-Baranova L.S. Chickenpox breakthrough: Has the situation a new scheme of prevention. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2011; 6 (8): 18─22.
29. Druzhinina T.A. Chickenpox in the Yaroslavl region. Cost-effectiveness of vaccination of one age group of children against chickenpox. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2012; 9 (5): 14─21.
Review
For citations:
Raiskii D.V., Dzhumagaziev A.A., Dzhal'mukhamedova E.I., Kvyatkovskii I.E. PHARMACOECONOMIC ANALYSIS OF CHICKENPOX IMMUNE PREVENTION EFFECTIVENESS IN THE INFANT ORPHANAGE INMATES. Pediatric pharmacology. 2014;11(6):24-29. (In Russ.) https://doi.org/10.15690/pf.v11i6.1212
Views:
901
Email this article 